Prediction of auditory brain stem responses damage in patients with head-and-neck cancers receiving radiotherapy using the functional assays of normal tissue complication probability models.

AIM: The purpose of this study was to set four NTCP models on clinical data and develop a model that calculates the possibility of hearing damage due to irradiation of healthy and at-risk brainstem tissue. MATERIALS AND METHODS: ABR tests were performed on 50 head-and-neck cancer patients three years after radiotherapy for evaluation of lesions in a part of the auditory nerve or the auditory pathway in the brainstem. RESULTS: It indicated a significant difference in the latency of the waves assessed by the ABR test between the two groups. The paired sample t-test indicated the latency time of waves I, III, V, I-III, and I-V (P < 0.001) in the right ear, and in the left ear latency time of waves III, V, I-III, I-V, and III-V (P < 0.001) were significantly higher in the case group's ear than those in the control group. The confidence interval of the fitted parameters was 95% for NTCP models. ABR test's binary outcome with differential dose-volume histograms (dDVHs) was calculated and imported as input to the NTCP modeling. The values of the parameters n = 2.3-2.9 and the value s = 1 were obtained, which indicated that the brainstem organ is seriality. CONCLUSION: The best model ranked for the prediction of brainstem hearing damage was the logit model, which had the lowest Akaike value. The nervousness of the auditory organ of the brainstem (VIII nerve) can be declared as one of the reasons for being independent of the received dose.

Predicting severe radiation-induced oral mucositis in head and neck cancer patients using integrated baseline CT radiomic, dosimetry, and clinical features: A machine learning approach.

Purpose: To establish the early prediction models of radiation-induced oral mucositis (RIOM) based on baseline CT-based radiomic features (RFs), dosimetric data, and clinical features by machine learning models for head and neck cancer (HNC) patients. Methods: In this single-center prospective study, 49 HNCs treated with curative intensity modulated radiotherapy (IMRT) were enrolled. Baseline CT images (i.e., CT simulation), dosimetric, and clinical features were collected. RIOM was assessed using CTCAE v.5.0. RFs were extracted from manually-contoured oral mucosa structures. Minimum-redundancy-maximum-relevance (mRMR) method was applied to select the most informative radiomics, dosimetric, and clinical features. Then, binary prediction models were constructed for predicting acute RIOM based on the top mRMR-ranked radiomics, dosimetric, and clinical features alone or in combination, using random forest classifier algorithm. The predictive performance of models was assessed using the area under the receiver operating curve (AUC), accuracy, weighted-average based sensitivity, precision, and F1-measure. Results: Among extracted features, the top 10 RFs, the top 5 dose-volume features, and the top 5 clinical features were selected using mRMR method. The model exploiting the integrated features (10-radiomics + 5-dosimetric + 5-clinical) achieved the best prediction with AUC, accuracy, sensitivity, precision, and F1-measure values of 91.7 %, 90.0 %, 83.0 % 100.0 %, and 91.0 %, respectively. The model developed using baseline CT RFs alone provided the best performance compared to dose-volume features or clinical features alone, with an AUC of 87.0 %. Conclusion: Our results suggest that the integration of baseline CT radiomic features with dosimetric and clinical features showed promising potential to improve the performance of machine learning models in early prediction of RIOM. The ultimate goal is to personalize radiotherapy for HNC patients.

Pediatric effective dose assessment for routine computed tomography examinations in Tehran, Iran.

Background: The purpose of this study is to evaluate the effective dose (ED) for computed tomography (CT) examination in different age groups and medical exposure in pediatric imaging centers in Tehran, Iran. Methods: Imaging data were collected from 532 pediatric patients from four age groups subjected to three prevalent procedures. National Cancer Institute CT (NCICT) software was used to calculate the ED value. Results: The mean ED values were 1.60, 4.16, and 10.56 mSv for patients' procedures of head, chest, and abdomen-pelvis, respectively. This study showed a significant difference of ED value among five pediatric medical imaging centers (P < 0.05). In head, chest, and abdomen-pelvis exams, a reduction in ED was evident with decreasing patients' age. Conclusion: As there were significant differences among ED values in five pediatric medical imaging centers, optimizing this value is necessary to decrease this variation. For head CT in infants and also abdomen-pelvis, further reduction in radiation exposure is required.

Prediction of chronic kidney disease in abdominal cancers radiation therapy using the functional assays of normal tissue complication probability models.

Aim: The purpose of this study is to predict chronic kidney disease (CKD) in the radiotherapy of abdominal cancers by evaluating clinical and functional assays of normal tissue complication probability (NTCP) models. Materials and Methods: Radiation renal damage was analyzed in 50 patients with abdominal cancers 12 months after radiotherapy through a clinical estimated glomerular filtration rate (eGFR). According to the common terminology criteria for the scoring system of adverse events, Grade 2 CKD (eGFR ≤30-59 ml/min/1.73 m2) was considered as the radiation therapy endpoint. Modeling and parameter estimation of NTCP models were performed for the Lyman-equivalent uniform dose (EUD), the logit-EUD critical volume (CV), the relative seriality, and the mean dose model. Results: The confidence interval of the fitted parameters was 95%. The parameter value of D50 was obtained 22-38 Gy, and the n and s parameters were equivalent to 0.006 -3 and 1, respectively. According to the Akaike's information criterion, the mean dose model predicts radiation-induced CKD more accurately than the other models. Conclusion: Although the renal medulla consists of many nephrons arranged in parallel, each nephron has a seriality architecture as renal functional subunits. Therefore, based on this principle and modeling results in this study, the whole kidney organs may have a serial-parallel combination or a secret architecture.

Lifetime attributable cancer risk related to prevalent CT scan procedures in pediatric medical imaging centers.

PURPOSE: Evaluation of the organ dose in pediatric patients up to 15 years old and Estimation of lifetime attributable risk (LAR) of cancer incidence in pediatric computed tomography procedures. MATERIALS AND METHODS: Data from 532 patients below 15 years old was collected and they were categorized into four age groups of <1, 1-5, 5-10, and 10-15 years old. NCICT software was used to calculate the organ dose, and LAR of cancer incidence has been estimated according to the BEIR VII report. RESULTS: The highest median dose in all age groups was related to eye lens (head scan), thyroid (chest scan), and colon (abdomen-pelvic scan). The highest average LAR of cancer incidence was observed for breast cancer and colon cancer following a chest CT scan of the youngest group (<1-year-olds) [68.23 per 100,000] and abdomen-pelvic scans of the oldest group (10- to 15-year-olds) [57.30 per 100,000]. CONCLUSION: This study shows that the average LAR is higher in females and it decreases with age in both genders. Although CT scan has an indispensable application in diagnosis, the patient dose should be taken into account before any examination specifically in pediatric patients.

PEDIATRIC REGIONAL DRL ASSESSMENT IN COMMON CT EXAMINATIONS FOR MEDICAL EXPOSURE OPTIMIZATION IN TEHRAN, IRAN.

The main purpose of this pilot study was to assess the regional diagnostic reference level (RDRL) of computed tomography (CT) examinations to optimise medical exposure in five pediatric medical imaging centers in Tehran, Iran where the most frequent CT examinations were investigated. For each patient, CT volume dose indexes (CTDIvol) and dose length product (DLP) in each group were recorded and their third quartile was calculated and set as RDRL. Pediatrics were divided into four age groups (<1; 1-5; 5-10 and 10-15 years). Then, the third quartile values for head, chest and abdomen-pelvic CTs were, respectively, calculated for each group in terms of CTDIvol: 21.3, 24.4, 24.2 and 36.3 mGy; 2.9, 3.2, 3.7 and 5.7 mGy; 3.7, 5.7, 6.3 and 6.8 mGy; and in terms of DLP: 322.2, 390.1, 424.9 and 694.1 mGy.cm; 53.1, 115.2, 145.3 and 167.6 mGy.cm and 128.7, 317.7, 460.2 and 813.8 mGy.cm. Finally, RDRLs were compared with other countries and preceding data in Iran. As a result, CTDIVOL values were lower than other national and international studies except for chest and abdomen-pelvic values obtained in Europe. Moreover, this matter applied to DLP so that other formerly reported values were higher than the present study but European values for chest and abdomen-pelvic scans and also Tehran studies conducted in 2012. Variation of scan parameters (tube voltage (kVp), tube current (mAs) and scan length), CTDIvol and DLP of different procedures among different age groups were statistically significant (P-value < 0.05). The variations in dose between CT departments as well as between identical scanners suggest a large potential for optimization of examinations relative to which this study provides helpful data.

Estimation of Absorbed Dose of the Thyroid Gland in Patients Undergoing 64-Slice Head Computed Tomography and Comparison the Results with ImPACT Software and Computed Tomography Scan Dose Index.

Thyroid exposure to radiation in brain computed tomography (CT) scan is of great value since it is considered as a vital organ. This study aimed to investigate the absorbed dose of thyroid by various protocols of head CT in patients referring to 64-slice CT scan center and to compare the values with the calculated dose by imaging performance and assessment of CT (ImPACT) method. Also, the values of CT scan dose index (CTDI) were calculated with semiconductor detector. In this cross-sectional study, 120 outpatients including three groups of forty individuals over 40 years old referring to the hospital radiology centers in Tehran for head CT were chosen and 3 thermo-luminescence dosimeter (TLD-GR200) were applied on thyroid gland of each patient. For brain CT, Absorbed and effective doses of thyroid gland were calculated by ImPACT software. In addition, semiconductor detector in head CTDI phantom calculated CTDI for the applied protocols. Mean effective dose of thyroid gland in brain scan group was calculated by TLD and ImPACT software which showed no significant difference (P < 0.001). Mean effective dose of thyroid gland in unidirectional and bi-directional sinus scan by TLD and ImPACT software were different significantly (P < 0.001). Also, the differences between CTDI values shown by brain and sinus scan protocol with semiconductor detector and those CTDI were significant (P < 0.001). The calculated values of absorbed dose and effective doses of thyroid by TLD and ImPACT software were not significantly different. Mean effective dose calculated for thyroid gland in head scans by TLD and ImPACT was less than the annual permissive level for thyroid gland suggested by International Committee on Radiological Protection. In this study, calculated values of thyroid effective dose in brain scan with 64-slice scanner were less than the calculated values in a similar study.

Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy.

The biomedical applications of gold nanoparticles (AuNPs) have experienced rapid growth in recent years, due to their expected benefits in medical imaging and therapy. In this work, we report the development of a theranostic nanocomplex constructed from alginate hydrogel co-loaded with cisplatin and AuNPs (abbreviated as ACA) for simultaneous drug delivery and computed tomography imaging. CT26 cells derived from mouse colon adenocarcinoma were exposed to various concentrations of ACA nanocomplex (for 24 h) and the cytotoxicity was measured using MTT assay. Moreover, the cells treated with ACA nanocomplex were imaged in a computed tomography scanner and the contrast enhancement due to the presence of nanocomplex was assessed. The cytotoxicity results showed that ACA nanocomplex had a more potent chemotherapy efficacy than free cisplatin, so that ACA nanocomplex at the concentration of 5 µg/ml (per cisplatin) and 20 µg/ml of free cisplatin resulted in the same cytotoxicity (survival rate: 66%). The computed tomography imaging study revealed that ACA nanocomplex increased the brightness of computed tomography images, the computed tomography number value, and contrast-to-noise ratio (CNR). ACA nanocomplex can be presented as a computed tomography-traceable nanocarrier that allows to monitor the delivery of therapeutics by assessing their localized accumulation and in vivo biodistribution.

Determination of Examination-Specific Diagnostic Reference Level in Computed Tomography by A New Quality Control-Based Dose Survey Method.

A new "quality-control-based (QC-based) dose survey method" has been developed for determination of diagnostic reference levels (DRL) in Computed Tomography (CT) examinations. The "QC-based dose survey method" is based on the use of retrospective data in the QC documents and reports, which are typically available from the National Regulatory Authority database. The method was applied to 70 CT scanners in Tehran, Iran, by using the available QC reports from the database. The commonly used "data collection method" was also applied by filling each questionnaire on-site to validate the new method. Using the new QC-based and data collection methods, the DRLs of four common CT examinations: head, sinus, chest, and abdomen/pelvis were determined and compared. The DRLs determined by the "QC-based method" for head, sinus, chest, and abdomen/pelvis are 59, 29, 10, and 13 mGy, respectively, for the volume computed tomography dose index (CTDIVol) and 834, 235, 233, and 522 mGy-cm for the dose length product (DLP), respectively. The difference between the DRLs obtained by the two methods is on the average 6.7 ± 5.7%, which is within the acceptance tolerance level of the IAEA for QC dosimetry tests. The "QC-based dose survey method" is believed to be an effective alternative method to the other commonly used "data collection" and "direct dose measurement method" for determination of CT examination DRLs. This new method has unique characteristics such as simplicity, time and cost effectiveness, highly reduced clinical interruptions and collaborations, and potential for large-scale surveys with capability for more frequent review of national DRL values.

A "quality-control-based correction method" for displayed dose indices on CT scanner consoles in patient dose surveys.

PURPOSE: A new quality-control-based (QC-based) method is introduced to obtain correction factors to be applied to displayed patient dose indices (CTDIVol and DLP) on CT scanner consoles to verify improvement of dose surveys for diagnostic reference levels (DRLs) determination. METHOD: An available data-base of QC documents and reports of 57 CT scanners in Tehran, Iran was used to estimate CTDIVol, DLP and relevant correction factors for three CT examination types including head, chest and abdomen/pelvis. The correction factor is the ratio of QC-based estimated dose to displayed dose. A dose survey was performed by applying on-site "data collection method" and correction factors obtained in order to select CT scanners in three modes for determination of CT DRLs by inclusion of: (a) all CT scanners before displayed dose indices were corrected (57), (b) only CT scanners calibrated by QC experts (41) and (c) all CT scanners after displayed dose indices were corrected (57). RESULTS: For the 41 CT scanners, correction factors of three examination types obtained in this study are within the acceptance tolerance of IAEA HHS-19. The correction factors range from 0.45 to 1.7 (average of 3 examinations) which is due to the change in the calibrated value of CTDIVol over extended time. The DRL differences in three modes are within ±1.0% for CTDIVol and ±12.4% for DLP. CONCLUSIONS: The "QC-based correction method" applied to mode (c) has improved the DRLs obtained by other two modes. This method is a strong alternative to "direct dose measurement" with simplicity and cost effectiveness.

GANTRY ANGULATION EFFECTS ON CT DOSE ALONG THE Z-AXIS DIRECTION IN HEAD EXAMINATIONS.

The purpose of this study was to evaluate the effects of the gantry angulation on dose profiles along the z-axis, the CTDIW value and the CTDIW efficiency in the head examinations. A Monte Carlo simulation model of a GE LightSpeed 16-slice CT scanner was developed by a GATE toolkit. The CTDI100 in air at the isocenter and in a head dosimetry phantom were measured using a pencil ion chamber. Dose profiles were studied in the central and peripheral holes of the head phantom using thermoluminescence LiF disc dosemeters for gantry angulations of 0°, 10° and 20°. Results show a small shift for only the peripheral dose profiles with increasing the gantry angulation (maximum shift of 24 mm at 20°). The peak amplitude of the dose profiles was reduced for both of the central and peripheral holes by ~5%, while the CTDIW values and the CTDIW efficiencies did not change significantly.

EFFECTIVE DOSE IN TWO DIFFERENT DENTAL CBCT SYSTEMS: NEWTOM VGi AND PLANMECA 3D MID.

Cone beam computed tomography, CBCT, is a kind of CT scanner producing conical diverging X-rays, in which a large area of a two-dimensional detector is irradiated in each rotation. Different investigations have been performed on dosimetry of dental CBCT. As there is no special protocol for dental CBCT, CT scan protocols are used for dosimetry. The purpose of this study is measurement of dose to head and neck organs in two CBCT systems, i.e. Planmeca 3D Mid (PM) and NewTom VGi (NT), using thermoluminescence dosimetry and Rando phantom. The thermoluminescent dosimetry (TLD)-100 chips were put at the position of different organs of the head and neck. Two TLD-100 chips were inserted at each position, the dose values were measured for several different field sizes, i.e. 8 × 8, 12 × 8 and 15 × 15 cm2 for NewTom, and 10 × 10 and 20 × 17 cm2 for Planmeca systems. According to the results, the average effective dose in PM is much more than the NT system in the same field size, because of the greater mAs values. For routine imaging protocols used for NT, the effective dose values are 70, 73 and 121 µSv for 8 × 8, 12 × 8 and 15 × 15 cm2 field sizes, respectively. In PM, the effective dose in 10 × 10 cm2 and 17 × 20 cm2 is 259 and 341 µSv, respectively.

ESTIMATION OF CARDIAC CT ANGIOGRAPHY RADIATION DOSE TOWARD THE ESTABLISHMENT OF NATIONAL DIAGNOSTIC REFERENCE LEVEL FOR CCTA IN IRAN.

In recent years, with the introduction of 64-slice CT and dual-source CT technology, coronary CT angiography (CCTA) has emerged as a useful diagnostic imaging modality as a non-invasive assessment of coronary heart disease. CT produces a larger radiation dose than other imaging tests and cardiac CT involves higher radiation dose with the advances in the spatial and temporal resolution. The aims of this study are patient dose assessment and establishment of national diagnostic reference level for CCTA in Iran. A questionnaire was sent to CCTA centers. Data for patient and CT protocols were obtained. The volumetric CT dose index (CTDIvol), dose length product (DLP) and total DLP were considered in the 32 cm standard body phantom. Calculation of estimated effective dose (ED) was obtained by multiplying the DLP by a conversion factor [k = 0.014 mSv (mGy·cm)-1]. Mean value of CTDIvol and DLP for CCTA was 50 mGy and 825 mGy·cm. The third quartile (75th) of the distribution of mean CTDIvol (66.54 mGy) and DLP (1073 mGy·cm) values was expressed as the diagnostic reference level (DRL) for CCTA in Iran. The median of ED was 10.26 mSv and interquartile range of ED was 7.08-15.03 mSv. A large variety in CTDIvol and DLP among CT scanner and different sites due to variability in CT parameter is noted. It seems that training could help to reduce patient's dose.

Gastrointestinal Side Effects of the Radioiodine Therapy for the Patients with Differentiated Thyroid Carcinoma Two Days after Prescription.

Iodine-131 (I-131) therapy is one of the conventional approaches in the treatment of patients with differentiated thyroid carcinoma (DTC). The radioiodine agents also accumulate in the other organs that cause pain and damage to the patients. Radioiodine therapy is associated with various gastrointestinal (GI) toxicities. In this study, GI side effects of the radioiodine therapy were investigated. GI toxicities of the radioiodine therapy were studied in 137 patients with histologically proven DTC in Jun-Nov 2014. All the patients were treated by radioiodine agents in the research institute of Shariati Hospital, Tehran, Iran. The patients were examined 48 h after prescription (before discharge) and their GI side effects were registered. Correlation of the age, gender, administered dose, administered dose per body weight as the independent factors, and GI side effects were analyzed using the Pearson correlation test with Statistical Package for the Social Sciences (SPSS) version 20. Regression coefficients and linearity of the variable were investigated by MATLAB software. Line fitting was performed using MATLAB curve-fitting toolbox. From the subjects, 38 patients had GI complaints (30.4%). Significant factors influencing GI side effects were dose per body weight and administered doses. There was no significant correlation between age and gender as the independent parameters and GI complaints. The most prevalent GI side effect was nausea that occurs in 26.4% of the patients. From the results, it could be concluded that the GI side effects could be prevented by administering a safe radioiodine dose value less than 5,550 MBq.